Pancreas 3D Organoids: Current and Future Aspects as a Research Platform for Personalized Medicine in Pancreatic Cancer

被引：71

作者：

Moreira, Leticia ^{[1
,2
,3
]}

Bakir, Basil ^{[1
,2
]}

Chatterji, Priya ^{[1
,2
]}

Dantes, Zahra ^{[4
]}

Reichert, Maximilian ^{[4
]}

Rustgi, Anil K. ^{[1
,2
]}

机构：

[1] Univ Penn, Perelman Sch Med, Dept Med, Div Gastroenterol, Philadelphia, PA 19104 USA

[2] Univ Penn, Perelman Sch Med, Dept Genet, Div Gastroenterol, Philadelphia, PA 19104 USA

[3] Univ Barcelona, IDIBAPS, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Hosp Clin,Dept Gastroenterol, Catalonia, Spain

[4] Tech Univ Munich, Klinikum Rechts Isar, Med Klin & Poliklin 2, Munich, Germany

来源：

CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY | 2018年 / 5卷 / 03期

关键词：

3D Organoids; Pancreas; Adenocarcinoma; Personalized Medicine; ESOPHAGEAL EPITHELIAL-CELLS; STEM-CELLS; DUCTAL ADENOCARCINOMA; IN-VITRO; ONCOGENIC KRAS; DRUG RESPONSE; ADULT LIVER; MOUSE; CULTURE; SPHEROIDS;

D O I：

10.1016/j.jcmgh.2017.12.004

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Pancreatic ductal adenocarcinoma is one of the most aggressive forms of cancer, and the third leading cause of cancer-related mortality in the United States. Although important advances have been made in the last decade, the mortality rate of pancreatic ductal adenocarcinoma has not changed appreciably. This review summarizes a rapidly emerging model of pancreatic cancer research, focusing on 3-dimensional organoids as a powerful tool for several applications, but above all, representing a step toward personalized medicine.

引用

页码：289 / 298

页数：10

共 50 条

[31] Digital twins in cancer research and treatment: A future for personalized medicine
Heudel, Pierre Etienne
Renard, Felix
Attye, Arnaud
BULLETIN DU CANCER, 2023, 110 (10) : 1085 - 1087
[32] A Bibliometric Analysis of 3D Printing in Personalized Medicine Research from 2012 to 2022
Xue, Aile
Li, Wenjie
Tian, Wenxiu
Zheng, Minyue
Shen, Lan
Hong, Yanlong
PHARMACEUTICALS, 2023, 16 (11)
[33] Bioprinted Organoids Platform with Tumor Vasculature for Implementing Precision Personalized Medicine Targeted Towards Gastric Cancer
Kim, Jisoo
Kim, Jungmin
Gao, Ge
Choi, Yoo-mi
Kim, Jaewook
Cho, Dong-Woo
Cheong, Jae-Ho
Jang, Jinah
ADVANCED FUNCTIONAL MATERIALS, 2024, 34 (11)
[34] Personalized 3D printed scaffolds: The ethical aspects
van Daal, Manon
de Kanter, Anne-Floor J.
Bredenoord, Annelien L.
de Graeff, Nienke
NEW BIOTECHNOLOGY, 2023, 78 : 116 - 122
[35] 3D Printing as a Promising Tool in Personalized Medicine
Vanessa Marcia Vaz
Lalit Kumar
AAPS PharmSciTech, 22
[36] Pancreatic stellate cells and pancreas cancer: Current perspectives and future strategies
Haqq, Jonathan
Howells, Lynne M.
Garcea, Giuseppe
Metcalfe, Matthew S.
Steward, Will P.
Dennison, Ashley R.
EUROPEAN JOURNAL OF CANCER, 2014, 50 (15) : 2570 - 2582
[37] Magnetic 3D Bioprinting for Personalized Medicine.
Souza, G.
CYTOTHERAPY, 2020, 22 (05) : S21 - S22
[38] 3D Printing as a Promising Tool in Personalized Medicine
Vaz, Vanessa Marcia
Kumar, Lalit
AAPS PHARMSCITECH, 2021, 22 (01)
[39] Why 3D in vitro cancer models are the future of cancer research?
Petric, Tina
Sabol, Maja
PERIODICUM BIOLOGORUM, 2022, 124 (3-4) : 69 - 83
[40] A microfluidic platform for developing circulating tumor cells (CTCs) organoids for precision medicine in pancreatic cancer
Zhang, Yu
Smith, Scott
Nenwani, Minal
Gunchick, Valerie
Sahai, Vaibhav
Nagrath, Sunitha
Nagrath, Deepak
CANCER RESEARCH, 2023, 83 (08)

← 1 2 3 4 5 →